International Forum on Pharmacy and Pharmaceutical Policy (IFPPP - 26)

This track explores recent advancements in pharmacy policy that aim to enhance patient care and medication management. Participants will discuss the implications of these innovations on healthcare systems and regulatory frameworks.

This session focuses on the critical role of regulatory affairs in ensuring the safety and efficacy of pharmaceutical products. Experts will share insights on navigating complex regulatory landscapes and the impact on pharmacy practice.

This track examines the intersection of drug regulation and public health outcomes. Discussions will center on how effective regulatory policies can mitigate risks and improve access to essential medications.

This session highlights innovative research methodologies in the pharmaceutical field, emphasizing their importance in policy formulation. Participants will explore case studies that demonstrate the application of these methodologies in real-world settings.

This track addresses the challenges of maintaining compliance with ethical standards in pharmacy practice. Discussions will focus on best practices for ensuring adherence to regulations while promoting patient welfare.

This session explores various models of patient-centered care within pharmacy practice. Participants will discuss strategies for enhancing patient engagement and improving health outcomes through tailored pharmaceutical services.

This track focuses on the evolving landscape of pharmacy education and its impact on workforce development. Discussions will center on curriculum innovations and training programs that prepare pharmacists for future challenges.

This session examines the role of pharmaceutical policy in promoting health equity across diverse populations. Participants will discuss strategies to address disparities in access to medications and healthcare services.

This track delves into the critical aspects of drug safety and risk management in pharmacy practice. Experts will share insights on identifying, assessing, and mitigating risks associated with pharmaceutical products.

This session highlights innovative practice models that enhance the role of pharmacists in healthcare delivery. Participants will explore case studies that demonstrate successful implementation and outcomes of these models.

This track provides a platform for discussing global trends and challenges in pharmaceutical policy. Participants will share insights from various countries, highlighting best practices and lessons learned in policy development.